Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,204 results
- Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD): Complete Statistical AnalysisIndependent statistical analysis of Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery: Complete Statistical AnalysisIndependent statistical analysis of Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism: Complete Statistical AnalysisIndependent statistical analysis of Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02001051).
- Study of AERAS-402 in Healthy Infants: Complete Statistical AnalysisIndependent statistical analysis of Study of AERAS-402 in Healthy Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01198366).
- Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00807495).
- Study of Alwextin® Cream in Treating Epidermolysis Bullosa: Complete Statistical AnalysisIndependent statistical analysis of Study of Alwextin® Cream in Treating Epidermolysis Bullosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00825565).
- Study of ALXN1820 in Healthy Adult Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of ALXN1820 in Healthy Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04631562).
- Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation: Complete Statistical AnalysisIndependent statistical analysis of Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates: Complete Statistical AnalysisIndependent statistical analysis of Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of AMG 256 in Adult Subjects With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of AMG 256 in Adult Subjects With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3): Complete Statistical AnalysisIndependent statistical analysis of Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02735239).
- Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab: Complete Statistical AnalysisIndependent statistical analysis of Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of BGB-A317 in Participants With Previously Treated Unresectable HCC: Complete Statistical AnalysisIndependent statistical analysis of Study of BGB-A317 in Participants With Previously Treated Unresectable HCC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03419897).
- Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01251354).
- Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003): Complete Statistical AnalysisIndependent statistical analysis of Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04254978).
- Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain: Complete Statistical AnalysisIndependent statistical analysis of Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE): Complete Statistical AnalysisIndependent statistical analysis of Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE): primary endpoint results, effect estimate…
- Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations: Complete Statistical AnalysisIndependent statistical analysis of Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II): Complete Statistical AnalysisIndependent statistical analysis of Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05285137).
- Study of Cellutome System for Treatment of Individual Lesions in EB Pts: Complete Statistical AnalysisIndependent statistical analysis of Study of Cellutome System for Treatment of Individual Lesions in EB Pts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN): Complete Statistical AnalysisIndependent statistical analysis of Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN): primary endpoint results, effect estimate with…
- Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years: Complete Statistical AnalysisIndependent statistical analysis of Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders: Complete Statistical AnalysisIndependent statistical analysis of Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone: Complete Statistical AnalysisIndependent statistical analysis of Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab: Complete Statistical AnalysisIndependent statistical analysis of Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05204290).
- Study of Copanlisib in Hepatic or Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Study of Copanlisib in Hepatic or Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03172884).
- Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies: primary endpoint results, effect estimate with…
- Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit: Complete Statistical AnalysisIndependent statistical analysis of Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci: Complete Statistical AnalysisIndependent statistical analysis of Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) – Extension Phase: Complete Statistical AnalysisIndependent statistical analysis of Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants: Complete Statistical AnalysisIndependent statistical analysis of Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…